Guggenheim raised the price target for the Protara Therapeutics Inc (NASDAQ:TARA) stock to “a Buy”. The rating was released on July 10, 2023, according to finviz. The research report from Oppenheimer …
More Facts about Protara Therapeutics Inc (TARA) Stock that you might not know Videos